Advertisement
Organisation › Details
Aquila BioMedical Ltd.
Aquila BioMedical, Ltd. is an innovative preclinical contract research organization that offers clients world leading research expertise in Immuno-Oncology, Immunology and Multiplex Histology. Tailored services combine advanced models with protocolled techniques, to provide high-value data, defining both efficacy and the mechanism of action of drug candidate compounds. Aquila partners with world-leading academics to provide expert advice and data interpretation. *
Start | 2011-01-01 splitoff | |
Group | Spectris (Group) | |
Industry | preclinical research | |
Industry 2 | cancer immunotherapy (immuno-oncology, I-O) | |
Person | Marriage, Howard (Aquila BioMedical 201308 Chairman) | |
Person 2 | Doris, Clare (Aquila BioMedical 201308 COO) | |
Region | Edinburgh | |
Country | United Kingdom (GB) | |
Street | 9 Little France Road Nine Edinburgh Bioquarter | |
City | EH16 4UX Edinburgh, Scotland | |
Tel | +44-131-658-5164 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: Concept Life Sciences Holdings Ltd.. (10/30/17). "Press Release: Concept Life Sciences Announces Acquisition of Aquila BioMedical". Manchester. | ||
Record changed: 2023-07-10 |
Advertisement
More documents for Spectris (Group)
- [1] Charnwood Molecular Ltd.. (6/30/22). "Press Release: Lee Patterson Appointed as New CEO of Charnwood Molecular"....
- [2] Malvern Panalytical B.V.. (1/14/22). "Press Release: Malvern Panalytical Inc. and TA Instruments-Waters LLC Agree to Partial Settlement of Patent Infringement Lawsuit". Almelo....
- [3] Creoptix AG. (1/11/22). "Press Release: Malvern Panalytical Expands Pharmaceutical Drug Development Solutions through the Acquisition of Creoptix"....
- [4] Leukocare AG. (3/1/21). "Press Release: Leukocare and Malvern Collaborate on Stabilization and Formulation Development of COVID-19 Vaccines". Martinsried & Malvern....
- [5] Creoptix AG. (1/12/21). "Press Release: Domainex Invests in the Creoptix WAVEdelta to Strengthen Its Fragment-based Drug Discovery Platform. Strong Partnership Ahead". Wädenswil & Saffron Walden....
- [6] Creoptix AG. (11/25/20). "Press Release: Creoptix and oneservice Partner for WAVEsystem After-sales Support". Wädenswil (Zurich)....
- [7] Creoptix AG. (12/10/19). "Press Release: Creoptix Appoints Line Stigen Raquet as Chief Executive Officer". Wädenswil (Zurich)....
- [8] Creoptix AG. (9/30/19). "Press Release: Creoptix Closes Successful Series C Financing Round to Support Further Growth". Wädenswil (Zurich)....
- [9] Creoptix AG. (9/5/18). "Press Release: Creoptix Attracts Waters as Corporate Investor". Wädenswil (Zurich)....
- [10] Concept Life Sciences Holdings Ltd.. (1/26/18). "Press Release: Concept Life Sciences Group Acquired by Spectris plc". Manchester & Egham....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top